Related Experiment Video
Updated: Apr 27, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines
Nicolas Hegerle1, Nicole Guiso
1Institut Pasteur, Unité de Prévention et Thérapies Moléculaires des Maladies Humaines, 25-28 rue du Dr Roux F-75015 Paris, France.
Abstract:
Bordetella pertussis causes whooping cough in humans, a highly transmissible respiratory disease life threatening for unvaccinated infants. Vaccination strategies were thus introduced worldwide with great success in developed countries reaching high vaccine coverage with efficacious vaccines. In the late 20th/early 21st century, acellular pertussis vaccines replaced whole cell pertussis vaccines but B. pertussis still circulates and evolves in humans, its only known reservoir. The latest transformation of this pathogen, and of its close relative Bordetella parapertussis, is the loss of pertactin production, a virulence factor included in different acellular pertussis vaccines. The real impact of this evolution on acellular pertussis vaccines efficacy and effectiveness should be assessed through standardized surveillance and isolation of B. pertussis and B. parapertussis worldwide.
More Related Videos
Related Concept Videos
Diphtheria
Regulation of Bacterial Virulence
Vaccines
Atypical Pneumonia
Vaccinations
Microorganisms in Medicine and Therapeutics

